# EDGAR Filing Document

**Accession Number:** 0001278387
**File Stem:** 0000919574-25-005382
**Filing Date:** 2025-8
**Character Count:** 5299
**Document Hash:** 5bba412dbe4fece406f49cfbbeadbb0e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000919574-25-005382.hdr.sgml**: 20250829

**ACCESSION NUMBER**: 0000919574-25-005382

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250829

**EFFECTIVENESS DATE**: 20250829

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BROADWOOD CAPITAL INC
- **CENTRAL INDEX KEY:** 0001278387

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** NY
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-13773
- **FILM NUMBER:** 251280201

**BUSINESS ADDRESS:**
- **STREET 1:** 156 WEST 56TH STREET
- **STREET 2:** 3RD FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10019
- **BUSINESS PHONE:** 212-508-5735

**MAIL ADDRESS:**
- **STREET 1:** 156 WEST 56TH STREET
- **STREET 2:** 3RD FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10019

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001278387

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** BROADWOOD CAPITAL INC

**Address:** 156 West 56th Street, NEW YORK, NY 10019

**Telephone number:** 212-508-5735

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-13773

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 1

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                             | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| AXON ENTERPRISE INC           | 05464C101 | 05/29/2025     | Proposal No. 2 requests that shareholders vote to approve, on an advisory basis, the compensation of the Company's named executive officers. | SECTION 14A SAY-ON-PAY VOTES |         565236 |           130839 | FOR         |                                        0 | FOR                         |  |
| LINEAGE CELL THERAPEUTICS INC | 53566P109 | 06/26/2025     | To approve, on an advisory basis, the compensation paid to our named executive officers.                                                     | SECTION 14A SAY-ON-PAY VOTES |       49560992 |                0 | FOR         |                                        0 | FOR                         |  |
| MONSTER BEVERAGE CORP NEW     | 61174X109 | 06/12/2025     | Proposal to approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.                           | SECTION 14A SAY-ON-PAY VOTES |        7698213 |           557215 | FOR         |                                        0 | FOR                         |  |
| OLO INC                       | 68134L109 | 06/12/2025     | To approve, on a non-binding advisory basis, the compensation of our named executive officers.                                               | SECTION 14A SAY-ON-PAY VOTES |        3394444 |           255457 | FOR         |                                        0 | FOR                         |  |
| INSIGHT MOLECULAR DIA INC     | 68235C206 | 06/27/2025     | To approve, on a non-binding advisory basis, Oncocyte's named executive officer compensation for the year ended December 31, 2024.           | SECTION 14A SAY-ON-PAY VOTES |       11410100 |                0 | FOR         |                                        0 | FOR                         |  |
| STAAR SURGICAL CO             | 852312305 | 06/18/2025     | Non-binding advisory vote to approve the compensation of our named executive officers.                                                       | SECTION 14A SAY-ON-PAY VOTES |       12696579 |           822912 | FOR         |                                        0 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** BROADWOOD CAPITAL INC

**By (Signature):** /s/ Neal C. Bradsher

**By (Printed Signature):** /s/ Neal C. Bradsher

**By (Title):** President

**Date:** 08/29/2025